ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,387Medicare Part D Prescriptions Filled, Including Refills

Rank: 119 out of 1121

$1.03M Total Retail Price of All Prescriptions

Rank: 66 out of 1121

652 Patients Receiving at Least One Drug in Part D
46%Patients 65 Years and Older
78% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 652 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

21% of this provider’s 652 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 6,809 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
METOPROLOL TARTRATE 623 281 1 9
LEVOTHYROXINE SODIUM 550 238 2 2
OMEPRAZOLE 530 228 3 6
HYDROCODONE-ACETAMINOPHEN 519 223 S3 4 3
LISINOPRIL 513 203 5 4
FUROSEMIDE 451 226 6 7
SIMVASTATIN 407 214 7 1
METFORMIN HCL 398 155 8 8
SPIRIVA 338 110 9 49
GABAPENTIN 321 118 10 13
PROAIR HFA 304 122 11 48
ZOLPIDEM TARTRATE 296 62 12 19
RANITIDINE HCL 247 73 13 33
AMITRIPTYLINE HCL 241 84 R 14 61
AZITHROMYCIN 221 88 15 44
ATORVASTATIN CALCIUM 207 103 16 15
DICLOFENAC SODIUM 200 76 17 112
AMLODIPINE BESYLATE 200 85 17 5
WARFARIN SODIUM 194 130 19 11
CITALOPRAM HBR 171 63 20 18
OXYCODONE HCL-ACETAMINOPHEN 164 50 S2 21 86
PRAVASTATIN SODIUM 163 56 22 14
ADVAIR DISKUS 158 40 23 64
POTASSIUM CHLORIDE 154 100 24 12
ATENOLOL 151 73 25 16
LOVASTATIN 147 43 26 26
METHYLPREDNISOLONE 143 71 27 97
VENTOLIN HFA 133 25 28 92
NEXIUM 130 41 29 24
TRAZODONE HCL 129 41 30 40
CYMBALTA 124 32 31 50
ROPINIROLE HCL 121 41 32 91
LANTUS 121 64 32 52
PROMETHAZINE HCL 121 19 R 32 67
PANTOPRAZOLE SODIUM 121 32 32 29
FLUTICASONE PROPIONATE 115 48 36 36
DEXILANT 110 35 37 136
GEMFIBROZIL 109 24 38 88
THEOPHYLLINE ANHYDROUS 107 45 39 175
GLIPIZIDE 104 59 40 84
MORPHINE SULFATE ER 103 40 S2 41 87
HYDROCHLOROTHIAZIDE 102 65 42 10
CIPROFLOXACIN HCL 96 56 43 57
HYDRALAZINE HCL 92 59 44 66
ENDOCET 90 32 S2 45 107
SINGULAIR 89 24 46 78
INSULIN SYRINGE 81 39 47 77
AMOXICILLIN 81 26 47 140
CARVEDILOL 78 48 49 20
CYCLOBENZAPRINE HCL 77 15 R 50 83
FLUOXETINE HCL 77 41 50 60
ALENDRONATE SODIUM 77 46 50 37
CLOPIDOGREL 75 36 53 27
IBUPROFEN 75 11 53 110
COMBIVENT 75 16 53 129
NYSTATIN 73 29 56 147
FLUCONAZOLE 72 23 57 156
METOCLOPRAMIDE HCL 72 36 57 120
SERTRALINE HCL 71 26 59 21
PLAVIX 66 33 60 42
TAMSULOSIN HCL 65 46 61 32
DIOVAN 65 38 61 45
METOPROLOL SUCCINATE 64 36 63 23
ZETIA 62 16 64 80
MELOXICAM 62 28 64 22
POLYETHYLENE GLYCOL 3350 62 37 64 70
PAROXETINE HCL 59 24 67 58
GLIPIZIDE ER 57 18 68 142
MONTELUKAST SODIUM 57 18 68 144
LIPITOR 56 31 70 106
LOSARTAN POTASSIUM 56 43 70 17
DIGOXIN 56 45 70 59
TRAMADOL HCL 55 32 73 25
TOPIRAMATE 55 0 73 202
LISINOPRIL-HYDROCHLOROTHIAZIDE 55 16 73 31
JANUVIA 53 26 76 81
LEVOFLOXACIN 53 18 76 79
GLYBURIDE 52 0 R 78 51
CHLORZOXAZONE 52 0 R 78 382
KLOR-CON 10 52 0 78 69
DOXYCYCLINE HYCLATE 51 18 81 103
ALLOPURINOL 50 33 82 30
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.